Back to mobile site

UPDATE: Jefferies Assumes Teva Pharma (TEVA) at Buy

October 20, 2022 4:26 PM EDT Send to a Friend
(Updated - October 21, 2022 7:43 AM EDT)

Jefferies analyst Glen Santangelo assumes coverage on Teva Pharma (NYSE: TEVA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login